137 related articles for article (PubMed ID: 29484186)
1. Characterisation of anti-alpha toxin antibody levels and colonisation status after administration of an investigational human monoclonal antibody, MEDI4893, against
Ruzin A; Wu Y; Yu L; Yu XQ; Tabor DE; Mok H; Tkaczyk C; Jensen K; Bellamy T; Roskos L; Esser MT; Jafri HS
Clin Transl Immunology; 2018; 7(1):e1009. PubMed ID: 29484186
[TBL] [Abstract][Full Text] [Related]
2. Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults.
Yu XQ; Robbie GJ; Wu Y; Esser MT; Jensen K; Schwartz HI; Bellamy T; Hernandez-Illas M; Jafri HS
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795368
[TBL] [Abstract][Full Text] [Related]
3. Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity
Tkaczyk C; Semenova E; Shi YY; Rosenthal K; Oganesyan V; Warrener P; Stover CK; Sellman BR
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150481
[TBL] [Abstract][Full Text] [Related]
4. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
5. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893.
Tabor DE; Yu L; Mok H; Tkaczyk C; Sellman BR; Wu Y; Oganesyan V; Slidel T; Jafri H; McCarthy M; Bradford P; Esser MT
Antimicrob Agents Chemother; 2016 Sep; 60(9):5312-21. PubMed ID: 27324766
[TBL] [Abstract][Full Text] [Related]
7. Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.
Diep BA; Hilliard JJ; Le VT; Tkaczyk C; Le HN; Tran VG; Rao RL; Dip EC; Pereira-Franchi EP; Cha P; Jacobson S; Broome R; Cheng LI; Weiss W; Prokai L; Nguyen V; Stover CK; Sellman BR
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115346
[TBL] [Abstract][Full Text] [Related]
8. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.
Wu Y; Liu X; Akhgar A; Li JJ; Mok H; Sellman BR; Yu L; Roskos LK; Esser MT; Ruzin A
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263109
[No Abstract] [Full Text] [Related]
10. MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model.
Hua L; Cohen TS; Shi Y; Datta V; Hilliard JJ; Tkaczyk C; Suzich J; Stover CK; Sellman BR
Antimicrob Agents Chemother; 2015 Aug; 59(8):4526-32. PubMed ID: 25987629
[TBL] [Abstract][Full Text] [Related]
11. Alpha-Toxin Contributes to Biofilm Formation among Staphylococcus aureus Wound Isolates.
Anderson MJ; Schaaf E; Breshears LM; Wallis HW; Johnson JR; Tkaczyk C; Sellman BR; Sun J; Peterson ML
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29659477
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting
Magyarics Z; Leslie F; Bartko J; Rouha H; Luperchio S; Schörgenhofer C; Schwameis M; Derhaschnig U; Lagler H; Stiebellehner L; Firbas C; Weber S; Campanaro E; Jilma B; Nagy E; Stevens C
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138568
[TBL] [Abstract][Full Text] [Related]
13. Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.
Le VT; Tkaczyk C; Chau S; Rao RL; Dip EC; Pereira-Franchi EP; Cheng L; Lee S; Koelkebeck H; Hilliard JJ; Yu XQ; Datta V; Nguyen V; Weiss W; Prokai L; O'Day T; Stover CK; Sellman BR; Diep BA
Antimicrob Agents Chemother; 2016 Oct; 60(10):5640-8. PubMed ID: 27401576
[TBL] [Abstract][Full Text] [Related]
14. Associations of pathogen-specific and host-specific characteristics with disease outcome in patients with
Sharma-Kuinkel BK; Tkaczyk C; Bonnell J; Yu L; Tovchigrechko A; Tabor DE; Park LP; Ruffin F; Esser MT; Sellman BR; Fowler VG; Ruzin A
Clin Transl Immunology; 2019; 8(7):e01070. PubMed ID: 31360464
[TBL] [Abstract][Full Text] [Related]
15. Survival during influenza-associated bacterial superinfection improves following viral- and bacterial-specific monoclonal antibody treatment.
Robinson KM; Ramanan K; Tobin JM; Nickolich KL; Pilewski MJ; Kallewaard NL; Sellman BR; Cohen TS; Alcorn JF
JCI Insight; 2019 Jul; 4(14):. PubMed ID: 31341107
[TBL] [Abstract][Full Text] [Related]
16. S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine.
Marshall HS; Baber J; Richmond P; Nissen M; Shakib S; Kreiswirth BN; Zito ET; Severs J; Eiden J; Gruber W; Jansen KU; Jones CH; Anderson AS
J Infect; 2019 Dec; 79(6):582-592. PubMed ID: 31585191
[TBL] [Abstract][Full Text] [Related]
17. Antibody response in Staphylococcus aureus septicaemia--a prospective study.
Colque-Navarro P; Söderquist B; Holmberg H; Blomqvist L; Olcén P; Möllby R
J Med Microbiol; 1998 Mar; 47(3):217-25. PubMed ID: 9511827
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Weisman MH; Moreland LW; Furst DE; Weinblatt ME; Keystone EC; Paulus HE; Teoh LS; Velagapudi RB; Noertersheuser PA; Granneman GR; Fischkoff SA; Chartash EK
Clin Ther; 2003 Jun; 25(6):1700-21. PubMed ID: 12860493
[TBL] [Abstract][Full Text] [Related]
19. A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-
Peck M; Rothenberg ME; Deng R; Lewin-Koh N; She G; Kamath AV; Carrasco-Triguero M; Saad O; Castro A; Teufel L; Dickerson DS; Leonardelli M; Tavel JA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910894
[No Abstract] [Full Text] [Related]
20. Characterisation of methicillin-resistant Staphylococcus aureus clinical isolates from animals in New Zealand, 2012-2013, and subclinical colonisation in dogs and cats in Auckland.
Karkaba A; Benschop J; Hill KE; Grinberg A
N Z Vet J; 2017 Mar; 65(2):78-83. PubMed ID: 27604152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
